DK1131094T3 - Multivalent T.d.Poliovaccine mod mindst difteri, poliomyelitis og tetanus - Google Patents

Multivalent T.d.Poliovaccine mod mindst difteri, poliomyelitis og tetanus

Info

Publication number: DK1131094T3
Authority: DK; Denmark
Prior art keywords: vaccine; diphtheria; poliovaccine; poliomyelitis; tetanus
Prior art date: 1998-11-26

Application number

DK99972544T

Other languages

English (en)

Inventor

Jean Rene Cartier

Patrick Laroche

Original Assignee

Aventis Pasteur Msd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-26

Filing date

1999-11-25

Publication date

2005-02-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8233032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1131094(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-25 Application filed by Aventis Pasteur Msd filed Critical Aventis Pasteur Msd

2005-02-14 Application granted granted Critical

2005-02-14 Publication of DK1131094T3 publication Critical patent/DK1131094T3/da

Links

206010013023 diphtheria Diseases 0.000 title abstract 2
208000000474 Poliomyelitis Diseases 0.000 title 1
206010043376 Tetanus Diseases 0.000 title 1
229960001539 poliomyelitis vaccine Drugs 0.000 title 1
229960005486 vaccine Drugs 0.000 abstract 6
241000991587 Enterovirus C Species 0.000 abstract 3
241000193449 Clostridium tetani Species 0.000 abstract 2
241000186216 Corynebacterium Species 0.000 abstract 2
239000000427 antigen Substances 0.000 abstract 2
102000036639 antigens Human genes 0.000 abstract 2
108091007433 antigens Proteins 0.000 abstract 2
SGNXVBOIDPPRJJ-PSASIEDQSA-N 1-[(1r,6r)-9-azabicyclo[4.2.1]non-4-en-5-yl]ethanone Chemical compound CC(=O)C1=CCC[C@@H]2CC[C@H]1N2 SGNXVBOIDPPRJJ-PSASIEDQSA-N 0.000 abstract 1
AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 abstract 1
239000003948 anatoxin Substances 0.000 abstract 1
230000016615 flocculation Effects 0.000 abstract 1
238000005189 flocculation Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK99972544T 1998-11-26 1999-11-25 Multivalent T.d.Poliovaccine mod mindst difteri, poliomyelitis og tetanus DK1131094T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98122373A EP1004314A1 (fr)	1998-11-26	1998-11-26	Vaccin T.d. Polio rappel pour une population vaccinée ou sensibilisée
EP99972544A EP1131094B1 (fr)	1998-11-26	1999-11-25	Vaccin t.d.polio multivalent contre au moins la diphterie, la poliomyelite et le tetanos

Publications (1)

Publication Number	Publication Date
DK1131094T3 true DK1131094T3 (da)	2005-02-14

Family

ID=8233032

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99972544T DK1131094T3 (da)	1998-11-26	1999-11-25	Multivalent T.d.Poliovaccine mod mindst difteri, poliomyelitis og tetanus

Country Status (14)

Country	Link
EP (2)	EP1004314A1 (da)
JP (1)	JP2003525858A (da)
AT (1)	ATE281176T1 (da)
AU (1)	AU759221B2 (da)
CA (1)	CA2352617A1 (da)
CZ (1)	CZ20011860A3 (da)
DE (1)	DE69921682T2 (da)
DK (1)	DK1131094T3 (da)
ES (1)	ES2228175T3 (da)
NZ (1)	NZ511933A (da)
PL (1)	PL347719A1 (da)
PT (1)	PT1131094E (da)
WO (1)	WO2000030678A1 (da)
ZA (1)	ZA200103634B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0616306D0 (en) *	2006-08-16	2006-09-27	Novartis Ag	Vaccines
EA015964B1 (ru)	2006-09-07	2012-01-30	Глаксосмитклайн Байолоджикалс С.А.	Вакцина
BR112020000999A2 (pt)	2017-07-18	2020-07-14	Serum Institute Of India Pvt Ltd.	composição imunogênica tendo estabilidade aperfeiçoada, imunogenicidade melhorada e reatogenicidade reduzida e processo para a sua preparação
CA3115803A1 (en)	2018-10-12	2020-04-16	Serum Institute Of India Private Ltd.	Combination vaccine composition comprising reduced dose inactivated poliovirus and method for preparing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2259415A1 (en) *	1996-07-02	1998-01-08	Connaught Laboratories Limited	Multivalent dtp-polio vaccines
GB9623233D0 (en) *	1996-11-07	1997-01-08	Smithkline Beecham Biolog	Vaccine composition
AU4707097A (en) *	1997-09-15	1999-04-05	Pasteur Merieux Serums Et Vaccins	Multivalent vaccines
GB9806456D0 (en) *	1998-03-25	1998-05-27	Smithkline Beecham Biolog	Vaccine composition

1998
- 1998-11-26 EP EP98122373A patent/EP1004314A1/fr not_active Withdrawn
1999
- 1999-11-25 EP EP99972544A patent/EP1131094B1/fr not_active Revoked
- 1999-11-25 CA CA002352617A patent/CA2352617A1/en not_active Abandoned
- 1999-11-25 DE DE69921682T patent/DE69921682T2/de not_active Revoked
- 1999-11-25 NZ NZ511933A patent/NZ511933A/xx unknown
- 1999-11-25 CZ CZ20011860A patent/CZ20011860A3/cs unknown
- 1999-11-25 JP JP2000583561A patent/JP2003525858A/ja not_active Withdrawn
- 1999-11-25 DK DK99972544T patent/DK1131094T3/da active
- 1999-11-25 PL PL99347719A patent/PL347719A1/xx not_active Application Discontinuation
- 1999-11-25 AU AU13901/00A patent/AU759221B2/en not_active Ceased
- 1999-11-25 AT AT99972544T patent/ATE281176T1/de not_active IP Right Cessation
- 1999-11-25 ES ES99972544T patent/ES2228175T3/es not_active Expired - Lifetime
- 1999-11-25 WO PCT/FR1999/002913 patent/WO2000030678A1/fr not_active Ceased
- 1999-11-25 PT PT99972544T patent/PT1131094E/pt unknown
2001
- 2001-05-04 ZA ZA200103634A patent/ZA200103634B/en unknown

Also Published As

Publication number	Publication date
PT1131094E (pt)	2005-02-28
DE69921682T2 (de)	2005-11-03
ES2228175T3 (es)	2005-04-01
WO2000030678A1 (fr)	2000-06-02
ATE281176T1 (de)	2004-11-15
EP1004314A1 (fr)	2000-05-31
EP1131094A1 (fr)	2001-09-12
JP2003525858A (ja)	2003-09-02
DE69921682D1 (de)	2004-12-09
NZ511933A (en)	2002-09-27
AU1390100A (en)	2000-06-13
PL347719A1 (en)	2002-04-22
AU759221B2 (en)	2003-04-10
CZ20011860A3 (cs)	2002-01-16
ZA200103634B (en)	2002-05-06
EP1131094B1 (fr)	2004-11-03
CA2352617A1 (en)	2000-06-02

Publication	Publication Date	Title
EA200201240A1 (ru)	2003-06-26	Поливалентная вакцинная композиция
GB9713156D0 (en)	1997-08-27	Vaccines
DK0865297T3 (da)	2003-03-03	Vaccinesammensætninger til intranasal administration omfattende chitosan og anvendelsen deraf
DK0654086T3 (da)	2000-06-13	Vacciner mod Aujeszky's sygdom og andre dyresygdomme indeholdende mutanter af pseudo-rabies-virus
ES2180651T3 (es)	2003-02-16	Vacuna que contiene acidos nucleicos.
LU91732I2 (fr)	2011-03-14	Menveo- oligosaccharide méningococcique du group A conjugué à la protéine CRM197 de Corynebacterium diphteriae.
BR9813930A (pt)	2006-12-19	antìgeno neisserial
BR9814483A (pt)	2000-10-10	"vacina"
CY1106206T1 (el)	2011-06-08	Φαρμακευτικη συνθεση πepιεχουσα φενοφιβρατη και μεθοδος παρασκευης της
EP1286207A4 (en)	2004-09-22	Projector and projection display system and method, and recorded medium
BR0206293A (pt)	2005-10-25	Composições de imunização e métodos de uso
DK0988862T3 (da)	2006-12-27	Formulering indeholdende et antigen, en TH-1 inducerende adjuvant og en sparsomt vandoplöselig aminosyre til brug ved immunisering
ATE364198T1 (de)	2007-06-15	1,3-dihydro-1-oxo-2h-indenderivat
CY1108526T1 (el)	2014-04-09	Εμβολια εναντι καρκινων
ATE244578T1 (de)	2003-07-15	Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit
DK0497121T3 (da)	1997-05-05	Hidtil ukendte tetrazolderivater, fremgangsmåde til fremstilling af disse og anvendelsen af disse
PL347719A1 (en)	2002-04-22	Multivalent t.d. polio vaccine against at least diphtheria, poliomyelitis and tetanus
DK0387821T3 (da)	1994-09-19	2-Alkyl-4-arylmethylchinoliner, deres anvendelse og lægemidler fremstillet hermed
DK1015026T3 (da)	2006-09-11	IL-12 som en adjuvans til Bordetella pertussis-vacciner
NL300336I1 (nl)	2008-04-01	Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
HUT77768A (hu)	1998-08-28	N-szubsztituált azabicikloheptánszármazékok, eljárás előállításukra és alkalmazásuk
DK0721782T3 (da)	2000-12-18	Influenzavaccine indeholdende pertussistoksin
DE69211161D1 (de)	1996-07-04	Antibiotische 7-aminonaphthazarinderivate
DE69708779D1 (de)	2002-01-17	Aufhänge- und Klemmsystem
DK0485463T3 (da)	1995-11-27	Svækket hundeparvovirus (CPV), vaccine omfattende CPV og fremgangsmåde til forebyggelse af CPV-infektion i hunde